Lee Willis C: insider trades.
Lee Willis C reported 6 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 6 open-market purchases ($18K) and 0 sales, across 1 company.
- Transactions
- 6
- Purchases (P)
- 6
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- LEE WILLIS C
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Emmaus Life Sciences, Inc. (EMMA) | Director, Officer · CEO | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-31 | Emmaus Life Sciences, Inc. | P | 100,000 | $0.05 | 690,167 | Form 4 |
| 2026-08-28 | Emmaus Life Sciences, Inc. | P | 94,767 | $0.06 | 590,167 | Form 4 |
| 2026-08-27 | Emmaus Life Sciences, Inc. | P | 50,000 | $0.05 | 495,400 | Form 4 |
| 2026-08-25 | Emmaus Life Sciences, Inc. | P | 46,000 | $0.04 | 445,400 | Form 4 |
| 2025-08-29 | Emmaus Life Sciences, Inc. | P | 170,000 | $0.01 | 275,400 | Form 4 |
| 2025-05-30 | Emmaus Life Sciences, Inc. | P | 70,000 | $0.02 | 229,400 | Form 4 |
Questions
What stock did Lee Willis C buy or sell?
Lee Willis C reported 6 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 6 open-market purchases ($18K) and 0 sales, across 1 company.
Is Lee Willis C the same person as other filers with this name?
This page covers SEC CIK 1517775 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/lee-willis-c-1517775.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.